The expression of Wiskott-Aldrich syndrome protein (WASP) is dependent on WASP-interacting protein (WIP).
暂无分享,去创建一个
[1] O. Danos,et al. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients , 2007, Gene Therapy.
[2] U. Pannicke,et al. Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro. , 2006, Experimental hematology.
[3] L. Meng,et al. WASP suppresses the growth defect of Saccharomyces cerevisiae las17Delta strain in the presence of WIP. , 2006, Biochemical and biophysical research communications.
[4] L. Naldini,et al. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation. , 2006, Human gene therapy.
[5] Mariko Sawa,et al. Caenorhabditis elegans WASP-interacting protein homologue WIP-1 is involved in morphogenesis through maintenance of WSP-1 protein levels. , 2006, Biochemical and biophysical research communications.
[6] C. Frecha,et al. Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences , 2005, Gene Therapy.
[7] P. Opolon,et al. A lentiviral vector encoding the human Wiskott–Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice , 2005, Gene Therapy.
[8] N. Caplen,et al. Kinase-Independent Functions for Itk in TCR-Induced Regulation of Vav and the Actin Cytoskeleton1 , 2005, The Journal of Immunology.
[9] Silvia Giliani,et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. , 2004, Blood.
[10] W. Vainchenker,et al. Mechanisms of WASp-mediated hematologic and immunologic disease. , 2004, Blood.
[11] T. Laín de Lera,et al. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] F. Candotti,et al. Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family. , 2004, Blood.
[13] J. Hartwig,et al. WIP Regulates Signaling via the High Affinity Receptor for Immunoglobulin E in Mast Cells , 2004, The Journal of experimental medicine.
[14] Kohsuke Imai,et al. Clinical course of patients with WASP gene mutations. , 2004, Blood.
[15] F. Candotti,et al. Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages. , 2004, Blood.
[16] H. Ochs. The Wiskott-Aldrich syndrome , 1998, Springer Seminars in Immunopathology.
[17] P. Doherty,et al. Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. , 2003, Blood.
[18] L. Notarangelo,et al. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation. , 2003, Current opinion in immunology.
[19] F. Candotti,et al. Autoimmunity in Wiskott-Aldrich syndrome , 2003, Current opinion in rheumatology.
[20] Michael J. Byrne,et al. WIP participates in actin reorganization and ruffle formation induced by PDGF , 2003, Journal of Cell Science.
[21] A. Nienhuis,et al. Functional correction of T cells derived from patients with the Wiskott–Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein , 2003, Gene Therapy.
[22] F. Candotti,et al. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. , 2003, The Journal of clinical investigation.
[23] K. Siminovitch,et al. The Wiskott–Aldrich syndrome protein: forging the link between actin and cell activation , 2003, Immunological reviews.
[24] F. Alt,et al. Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. , 2003, Blood.
[25] Alissa M. Weaver,et al. Cortactin Interacts with WIP in Regulating Arp2/3 Activation and Membrane Protrusion , 2003, Current Biology.
[26] Michael T. McManus,et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference , 2003, Nature Genetics.
[27] M. Gandhi,et al. X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome (WAS) gene that disrupts interaction with the WAS protein (WASP)-interacting protein (WIP). , 2003, Experimental hematology.
[28] Michael J. Byrne,et al. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. , 2002, Molecular cell.
[29] W. Lim,et al. Structure of the N-WASP EVH1 Domain-WIP Complex Insight into the Molecular Basis of Wiskott-Aldrich Syndrome , 2002, Cell.
[30] Adrian J. Thrasher,et al. Wasp in immune-system organization and function , 2002, Nature Reviews Immunology.
[31] L. Dupré,et al. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. , 2002, Immunity.
[32] G. Dunn,et al. Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp. , 2002, The international journal of biochemistry & cell biology.
[33] F. Candotti,et al. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction. , 2002, Human gene therapy.
[34] J. Hartwig,et al. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. , 2002, Immunity.
[35] T. Takenawa,et al. WASP and N-WASP in human platelets differ in sensitivity to protease calpain. , 2001, Blood.
[36] D. Nelson,et al. Somatic mosaicism in Wiskott–Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Abo,et al. A Role for Wiskott-Aldrich Syndrome Protein in T-cell Receptor-mediated Transcriptional Activation Independent of Actin Polymerization* , 2001, The Journal of Biological Chemistry.
[38] J. Hartwig,et al. WIP regulates N-WASP-mediated actin polymerization and filopodium formation , 2001, Nature Cell Biology.
[39] D. Haas,et al. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[40] P. Leibson,et al. Cutting Edge: WIP, a Binding Partner for Wiskott-Aldrich Syndrome Protein, Cooperates with Vav in the Regulation of T Cell Activation1 , 2000, The Journal of Immunology.
[41] Michael K. Rosen,et al. Autoinhibition and activation mechanisms of the Wiskott–Aldrich syndrome protein , 2000, Nature.
[42] S. Tsuboi,et al. Expression of human Wiskott–Aldrich syndrome protein in patients’ cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins , 2000, Gene Therapy.
[43] K. Siminovitch,et al. Antigen Receptor–Induced Activation and Cytoskeletal Rearrangement Are Impaired in Wiskott-Aldrich Syndrome Protein–Deficient Lymphocytes , 1999, The Journal of experimental medicine.
[44] F. Facchetti,et al. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott–Aldrich syndrome patients carrying ‘null’ mutations , 1999, Gene Therapy.
[45] Matthew D. Welch,et al. The Wiskott–Aldrich syndrome protein directs actin-based motility by stimulating actin nucleation with the Arp2/3 complex , 1999, Current Biology.
[46] D. Nelson,et al. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. , 1999, Journal of immunology.
[47] Laura M. Machesky,et al. Scar1 and the related Wiskott–Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex , 1998, Current Biology.
[48] R. Geha,et al. The Wiskott-Aldrich Syndrome Protein-interacting Protein (WIP) Binds to the Adaptor Protein Nck* , 1998, The Journal of Biological Chemistry.
[49] C. Kinnon,et al. Absence of expression of the Wiskott-Aldrich syndrome protein in peripheral blood cells of Wiskott-Aldrich syndrome patients. , 1998, Clinical immunology and immunopathology.
[50] Philip R. Cohen,et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. , 1998, Immunity.
[51] J. Hartwig,et al. WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[52] O. Majdic,et al. Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. , 1997, Blood.
[53] K. Miura,et al. N‐WASP, a novel actin‐depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2‐dependent manner downstream of tyrosine kinases. , 1996, The EMBO journal.
[54] L. Notarangelo,et al. Studies of the expression of the Wiskott-Aldrich syndrome protein. , 1996, The Journal of clinical investigation.
[55] U. Francke,et al. Wiskott–Aldrich Syndrome Protein, a Novel Effector for the GTPase CDC42Hs, Is Implicated in Actin Polymerization , 1996, Cell.
[56] U. Francke,et al. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome , 1994, Cell.